BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/18/2016 3:13:00 PM | Browse: 973 | Download: 1922
 |
Received |
|
2016-08-17 10:58 |
|
Peer-Review Started |
|
2016-08-17 18:54 |
|
To Make the First Decision |
|
2016-09-05 14:16 |
|
Return for Revision |
|
2016-09-07 10:25 |
|
Revised |
|
2016-09-13 22:54 |
|
Second Decision |
|
2016-09-22 17:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2016-09-28 18:59 |
|
Articles in Press |
|
2016-09-28 18:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2016-10-12 07:03 |
|
Typeset the Manuscript |
|
2016-11-13 13:22 |
|
Publish the Manuscript Online |
|
2016-11-18 15:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Naomi Khaing Than Hlaing, Debolina Banerjee, Robert Mitrani, Soe Htet Arker, Kyaw San Win, Nyan Lin Tun, Zaw Thant, Khin Maung Win and K Rajender Reddy |
| Funding Agency and Grant Number |
|
| Corresponding Author |
K Rajender Reddy, MD, Ruimy Family President’s Distinguished Professor of Medicine, Professor of Medicine in Surgery, Director of Hepatology, Director of the Viral Hepatitis Center, and Medical Director of Liver Transplantation, Division of Gastroenterology and Hepatology, University of Pennsylvania, 2 Dulles, 3400 Spruce Street, Philadelphia, PA 19104,
United States. rajender.reddy@uphs.upenn.edu
|
| Key Words |
Hepatitis C virus; Pegylated-interferon; Ribavirin; Sustained virologic response; Rapid virologic response |
| Core Tip |
peg-interferon (peg-IFN) and ribavirin (RBV) therapy was a viable treatment option for hepatitis C virus (HCV)-infected patients in Myanmar due to its availability and affordability. Currently, direct-acting antiviral agents are not widely accessible to the Myanmar population. Therefore, HCV treatment is still being conducted with peg-IFN and RBV therapy. This treatment regimen was shown to be reasonably efficacious with minimal adverse events. Fibrosis scores, baseline albumin, HCV RNA levels and rapid virologic response all independently predicted sustained virologic response.
|
| Publish Date |
2016-11-18 15:13 |
| Citation |
Hlaing NKT, Banerjee D, Mitrani R, Arker SH, Win KS, Tun NL, Thant Z, Win KM, Reddy KR. hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country. World J Gastroenterol 2016; 22(43): 9613-9622 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i43/9613.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i43.9613 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
